BioCentury
ARTICLE | Company News

J&J pharmaceuticals news

March 21, 2016 7:00 AM UTC

Johnson & Johnson’s Janssen Pharmaceutica N.V. and Johnson & Johnson Innovation units launched European incubator JLINX with undisclosed venture funding from the company’s J&J Innovation-JJDC venture arm. JLINX will host startups at Janssen’s campus in Beerse, Belgium, and provide access to J&J’s scientific, technical and business capabilities. J&J will make venture investments in the companies but will not hold rights to products they commercialize. J&J said it hopes to bring in external investors for JLINX companies. J&J said JLINX is accepting applications and will be fully operational this summer. The location is designed to house 15-20 companies. ...